Bicycle Therapeutics plc Stock Issued During Period, Value, Restricted Stock Award, Gross
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Bicycle Therapeutics plc stock issued during period, value, restricted stock award, gross for the quarter ending 2026-06-30 was $1.00K, a 0.00% change year-over-year.
- Bicycle Therapeutics plc stock issued during period, value, restricted stock award, gross for the quarter ending 2026-03-31 was $5.00K, a 150.00% increase year-over-year.
- Bicycle Therapeutics plc stock issued during period, value, restricted stock award, gross for the quarter ending 2025-09-30 was $1.00K.
- Bicycle Therapeutics plc stock issued during period, value, restricted stock award, gross for the quarter ending 2025-06-30 was $1.00K.
- Bicycle Therapeutics plc stock issued during period, value, restricted stock award, gross for fiscal 2025 was $4.00K, a 300.00% increase from fiscal 2024.
- Bicycle Therapeutics plc stock issued during period, value, restricted stock award, gross for fiscal 2024 was $1.00K, a 0.00% change from fiscal 2023.
- Bicycle Therapeutics plc stock issued during period, value, restricted stock award, gross for fiscal 2023 was $1.00K.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross 3 month | Stock Issued During Period, Value, Restricted Stock Award, Gross 12 month |
|---|---|---|
| 2026-06-30 | $1.00K 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $5.00K 10-Q · filed 2026-07-30 | |
| 2025-12-31 | $4.00K 10-K · filed 2026-03-17 | |
| 2025-09-30 | $1.00K 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $1.00K 10-Q · filed 2026-07-30 | |
| 2025-03-31 | $2.00K 10-Q · filed 2026-07-30 | |
| 2024-12-31 | $1.00K 10-K · filed 2026-03-17 | |
| 2024-03-31 | $1.00K 10-Q · filed 2025-10-30 | |
| 2023-12-31 | $1.00K 10-K · filed 2026-03-17 | |
| 2023-03-31 | $1.00K 10-Q · filed 2024-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |